Radio and PodcastRadio and PodcastLive Radio & Podcasts
Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease artwork
Science & Medicine

Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease

The Long Run with Luke Timmerman by The Long Run with Luke Timmerman

Dec 15, 202501:07:34Science & Medicine

Emily Conley, CEO of Berkeley, CA-based Renasant Bio, on developing small molecule correctors and potentiators for autosomal dominant polycystic kidney disease (ADPKD).

Related Episodes

Continue listening to more episodes from The Long Run with Luke Timmerman.